Luminex is making strategic moves, including plans to acquire a leading ATS, while operating as a major market participant in the U.S.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Luminex is making strategic moves, including plans to acquire a leading ATS, while operating as a major market participant in the U.S.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Luminex
biotech company based in Austin, Texas
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Market leadership is transitioning from large caps to small caps.
- Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.
- US market structure supports capital allocation.
- A company whose CEOs are merging is utilizing both the NYSE and Nasdaq as potential listing venues, with operations spanning Maryland and Pennsylvania.